Proteinase-activated receptors in fibroproliferative lung disease

Thorax

Volumn 69, Issue 2, 2014, Pages 190-192

  José, Ricardo J ^a   Williams, Andrew E ^a   Chambers, Rachel C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; WARFARIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASTHMA; BLOOD CLOTTING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG MECHANISM; FIBROPROLIFERATIVE LUNG DISEASE; FIBROSING ALVEOLITIS; HEMOSTASIS; HUMAN; INFLAMMATION; LUNG DISEASE; LUNG FIBROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE REPAIR;

ARDS; COPD PATHOLOGY; IDIOPATHIC PULMONARY FIBROSIS; INNATE IMMUNITY; INTERSTITIAL FIBROSIS; LUNG PROTEASES;

ASTHMA; BLOOD COAGULATION; FIBRINOLYSIS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, PROTEINASE-ACTIVATED; RESPIRATORY DISTRESS SYNDROME, ADULT; SIGNAL TRANSDUCTION;

EID: 84892520984     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-204367     Document Type: Article

References (13)

1. Chambers RC, Scotton CJ. Coagulation cascade proteinases in lung injury and fibrosis. ProcAm Thorac Soc 2012;9: 96-101.
2. Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 2005;105: 3178-84.
3. Kaneider NC, Leger AJ, Agarwal A, et al. "Role reversal" for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 2007;8: 1303-12. (Pubitemid 350131169)
4. Günther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000;161: 454-62. (Pubitemid 30129452)
5. Howell DCJ, Johns RH, Lasky JA, et al. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol 2005;166: 1353-65. (Pubitemid 40586507)
6. Mercer PF, Williams AE, Scotton CJ, et al. Proteinase-activated receptor-1, CCL2 and CCL7 regulate acute neutrophilic lung inflammation. Am J Respir Cell Mol Biol Published Online First: 23 Aug 2013.
7. Scotton CJ, Krupiczojc MA, Königshoff M, et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest 2009;119: 2550-63.
8. Mercer PF, Johns RH, Scotton CJ, et al. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am J Respir Crit Care Med 2009;179: 414-25.
9. Jenkins RG, Su X, Su G, et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006;116: 1606-14.
10. Wygrecka M, Kwapiszewska G, Jablonska E, et al. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183: 1703-14.
11. Noth I, Anstrom KJ, Calvert SB, et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186: 88-95.
12. Schmidlin F, Amadesi S, Dabbagh K, et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 2002;169: 5315-21. (Pubitemid 35217205)
13. Morrow DA, Braunwald E, Bonaca MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 2012;366: 1404-13.